| Body Mechanix Physical Therapy Pllc | |
|
5848 Snyder Dr, Lockport, NY 14094-9497 | |
| (716) 433-0070 | |
| (716) 433-1171 |
| Full Name | Body Mechanix Physical Therapy Pllc |
|---|---|
| Type | Facility |
| Speciality | Clinic/center - Physical Therapy |
| Location | 5848 Snyder Dr, Lockport, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063517662 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (New York) | Secondary |
| 261QP2000X | Clinic/center - Physical Therapy | (New York) | Primary |
| Provider Name | Kevin D Klein |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1144325143 PECOS PAC ID: 8921054297 Enrollment ID: I20050404000105 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago
| Provider Name | David C Batkowski |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902901911 PECOS PAC ID: 1658327929 Enrollment ID: I20050525000271 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Mallory Petrus |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467748731 PECOS PAC ID: 1355568874 Enrollment ID: I20140807000082 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Bryan T Wolfley |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1922528660 PECOS PAC ID: 8527331784 Enrollment ID: I20170911000197 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Mark Jospeh Siedlecki |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1124689542 PECOS PAC ID: 3476981747 Enrollment ID: I20200319002244 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago
| Provider Name | Caitlyn Elizabeth Mason |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1487379053 PECOS PAC ID: 4385012178 Enrollment ID: I20221129002028 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Body Mechanix Physical Therapy Pllc 5848 Snyder Dr, Lockport, NY 14094-9497 Ph: (716) 433-0070 | Body Mechanix Physical Therapy Pllc 5848 Snyder Dr, Lockport, NY 14094-9497 Ph: (716) 433-0070 |
News Archive
Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
In a recent Journal of Biological Chemistry "Paper of the Week," research led by Ayae Kinoshita at the Kyoto University Graduate School of Medicine in Japan reveals the benefits of exercise in combating Alzheimer's disease.
› Verified 8 days ago